Search

everythinglearnresearchcommunity

for

Search:↓

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

The book "Hair Replacement" is a detailed guide on hair transplant and treatments, useful for surgeons and clinicians.

Nano-quercetin improves quercetin's effectiveness in treating diseases but faces challenges in safety and production.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Environmental factors affect reproductive traits by altering the SRD5A1 gene.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

A 5% minoxidil spray could effectively treat male baldness with fewer side effects and better patient comfort.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.